Join the Gastric Bypass Surgery group to help and get support from people like you.
Gastric Bypass Surgery News (Page 2)
Weight-Loss Surgery Protects Liver Health
THURSDAY, Jan. 30, 2025 – Weight-loss surgery can protect the liver health of patients with obesity and fatty liver disease, a new study reports. Patients had a 72% lower risk of developing serious...
Patients With Diabetes Have Comparable Health Expenses After RYGB or Sleeve Gastrectomy
TUESDAY, Jan. 28, 2025 – For patients with diabetes undergoing Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG), overall expenditures decrease in the postsurgical period, with no...
Black Patients Less Likely To Get Weight Loss Surgery
TUESDAY, Jan. 21, 2025 – Black people with obesity are less likely to get weight-loss surgery than others. Black people are just as likely to discuss the procedure with their doctor – nearly 10%,...
Racial, Sex Disparities Seen in Discussion of, Progression to Weight Loss Surgery
FRIDAY, Jan. 17, 2025 – There are racial and sex disparities in the discussion of and progression to metabolic and bariatric surgery (MBS) among eligible patients, according to a study published...
American College of Gastroenterology, Oct. 25-30
The annual meeting of the American College of Gastroenterology was held from Oct. 25 to 30 in Philadelphia and attracted participants from around the world, including gastroenterology and digestive d...
Weight-Loss Surgery for Teens Brings Lasting Benefit
FRIDAY, Nov. 1, 2024 – Hillary Fisher thinks receiving weight-loss surgery as a teenager put her on the path to a better life. Fisher is one of 260 teens who participated in a long-term study which...
Trends in Obesity Treatment Show Surge in GLP-1 RAs, Drop in Surgeries
TUESDAY, Oct. 29, 2024 – Among privately insured patients, there was a doubling in the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) as antiobesity treatment from 2022 to 2023, with a...
Weight-Loss Surgeries Decline 25% as More Americans Turn to GLP-1 Meds
FRIDAY, Oct. 25, 2024 – As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim their waistlines, a new report finds....